Biomerica (BMRA) Return on Capital Employed Growth (3y) (2014 - 2026)
Biomerica (BMRA) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -247.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,318.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 362.00 |
| 10 | Biomerica | 6.20 Mn | 4.87 Mn | -44,000.00 | -4,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -4,422.00 |
| Nov 30, 2025 | -4,442.00 |
| Aug 31, 2025 | -5,023.00 |
| May 31, 2025 | -6,796.00 |
| Feb 28, 2025 | 9,174.00 |
| Nov 30, 2024 | 10,815.00 |
| Aug 31, 2024 | 8,742.00 |
| May 31, 2024 | 8,072.00 |
| Feb 29, 2024 | -4,905.00 |
| Nov 30, 2023 | -4,553.00 |
| Aug 31, 2023 | -4,885.00 |
| May 31, 2023 | -8,193.00 |
| Feb 28, 2023 | -9,725.00 |
| Nov 30, 2022 | -7,321.00 |
| Aug 31, 2022 | -6,315.00 |
| May 31, 2022 | -4,918.00 |
| Feb 28, 2022 | 800.00 |
| Nov 30, 2021 | -3,174.00 |
| Aug 31, 2021 | -2,988.00 |
| Aug 31, 2020 | 2,173.00 |